-
"Food and Drug Administration" classifies these antidepressants in drug category C, which means that there is currently not enough of "well-controlled" studies that would evaluate the risk of their
-
differences in vasoactive regulatory mechanisms. At the same time, it will investigate the possible beneficial effects of flavonoid administration in reducing the risk of developing cardiovascular complications
-
to better management of patients suffering from civilization diseases. Supervisor: doc. RNDr. Monika Barteková, PhD. Requirements Research FieldMedical sciences » Health sciencesEducation LevelMaster Degree
-
the aim of revealing differences in vasoactive regulatory mechanisms. At the same time, it will investigate the possible beneficial effects of flavonoid administration in reducing the risk of developing